Skip to main content
Mayinglong Pharmaceutical Group Co.,Ltd logo

Mayinglong Pharmaceutical Group Co.,Ltd — Investor Relations & Filings

Ticker · 600993 ISIN · CNE000001HN2 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 931 across all filing types
Latest filing 2024-04-12 Declaration of Voting R…
Country CN China
Listing Shanghai Stock Exchange 600993

About Mayinglong Pharmaceutical Group Co.,Ltd

https://www.mayinglong.cn/

Mayinglong Pharmaceutical Group Co.,Ltd. is a long-established enterprise specializing in the research, development, and production of Traditional Chinese Medicine (TCM). Founded in 1582, the company is widely recognized for its expertise in proctology, maintaining a dominant market position with its signature hemorrhoid ointments and suppositories. Its product portfolio also includes ophthalmic preparations, dermatological treatments, and gastrointestinal medicines. The company integrates traditional medicinal formulas with modern manufacturing technologies to provide healthcare solutions. Beyond pharmaceuticals, Mayinglong has expanded into healthcare services, including specialized hospitals and personal care products, focusing on the integration of clinical treatment and health management.

Recent filings

Filing Released Lang Actions
马应龙第十一届董事会第十二次会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 12th meeting of the 11th Board of Directors of Mayinglong Pharmaceutical Group Co., Ltd. It includes voting results on various reports and proposals related to the 2023 fiscal year, such as the General Manager's report, Audit Committee report, independent directors' reports, financial statements, profit distribution plan, annual report, internal control evaluation, ESG report, and other financial and governance matters. The document references that the detailed reports are published separately on the Shanghai Stock Exchange website and other official publications. The document itself is relatively short (3190 characters) and primarily serves as a formal announcement of board meeting decisions and approvals, not the full reports themselves. This fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially announces the voting outcomes of the board on key reports and proposals that will be submitted to the shareholders' meeting for approval.
2024-04-12 Chinese
马应龙2023年年度报告摘要
Annual Report Classification · 100% confidence The document is titled as the "2023 年年度报告摘要" which translates to "2023 Annual Report Summary". It contains detailed financial data including revenue, net profit, quarterly breakdowns, business segments, industry analysis, and company operations. It also includes audit information with a standard unqualified opinion from an accounting firm. The document is comprehensive, covering the company's financial performance, business overview, industry environment, and management discussion and analysis. The length is substantial (15,000 characters), indicating it is not a mere announcement or summary notice but a substantive report. These characteristics align with the definition of an Annual Report (10-K). FY 2023
2024-04-12 Chinese
马应龙2023年年度报告
Annual Report Classification · 100% confidence The document is titled '2023 年年度报告' which translates to '2023 Annual Report'. It contains detailed financial data, management discussion and analysis, company information, accounting policies, and audited financial statements. The document length is 15,000 characters, indicating a comprehensive report rather than a brief announcement. It includes sections such as management discussion and analysis, company governance, financial statements, and auditor's report, which are typical components of an official annual report. The presence of audited financial statements and detailed financial metrics confirms it is the full annual report, not just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K). FY 2023
2024-04-12 Chinese
马应龙2023年度环境、社会及治理（ESG）报告
Regulatory Filings
2024-04-12 Chinese
马应龙第十一届监事会第八次会议决议公告
Report Publication Announcement Classification · 95% confidence The document is a formal announcement of resolutions passed at the 11th Supervisory Board's 8th meeting of Mayinglong Pharmaceutical Group Co., Ltd. It includes approval of the 2023 Supervisory Board Work Report, the 2023 Annual Report and its summary, and the 2023 Internal Control Evaluation Report. The document states that these reports will be submitted to the shareholders' meeting for approval and that the full reports are published separately on the Shanghai Stock Exchange website and newspapers. The document itself is short (1064 characters) and serves as a notice of the meeting's resolutions and references the actual reports being published elsewhere. According to the "Menu vs Meal" rule, this is an announcement of reports, not the reports themselves. Therefore, the correct classification is Report Publication Announcement (RPA).
2024-04-12 Chinese
马应龙2023年度独立董事述职报告（齐 珺）
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director's Work Report" for the year 2023 by an independent director of a listed company. It details the director's attendance at board and shareholder meetings, participation in committees, oversight of financial reporting and internal controls, opinions on related party transactions, appointment of auditors and financial officers, and overall evaluation of the director's duties. The content focuses on governance, compliance with laws and regulations, and the director's role in supervision and decision-making. It does not contain financial statements or detailed financial performance data, nor is it an announcement or invitation to a meeting. This type of document is a report on board/management activities and governance oversight by an independent director, fitting best under Board/Management Information (MANG). The document length is 3123 characters, which is relatively short but contains substantive content about board activities rather than just an announcement or certification, so it is not RPA or RNS. Therefore, the classification is MANG with high confidence.
2024-04-12 Chinese

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.